Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

Point and Frameshift Mutations

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Mutations in Microorganisms

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...

Spontaneous and Induced Mutations

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).

Genome Copying Errors

Genome Copying Errors

DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.

Blood cancer journal·2026

Same author

Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target?

Atherosclerosis plus·2026

Same author

Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 Study.

EJHaem·2026

Same author

Distinct Longitudinal Patterns of Basal and Squamous Cell Carcinoma in Polycythemia Vera and Essential Thrombocythemia.

American journal of hematology·2026

Same author

Describing the use of ruxolitinib for the treatment of myelofibrosis: a plain language summary of the ROMEI early study results.

Future oncology (London, England)·2026

Same author

Venetoclax and gilteritinib combination for <i>FLT3</i>-mutated relapsed/refractory acute myeloid leukemia: a real-world single-center experience.

Haematologica·2026

Search research articles

Related Experiment Video

Updated: Oct 13, 2025

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

The MPL mutation.

Paola Guglielmelli¹, Laura Calabresi¹

¹Department of Experimental and Clinical Medicine, Center for Research and Innovation of Myeloproliferative Neoplasms (CRIMM), AOU Careggi, University of Florence, Florence, Italy.

International Review of Cell and Molecular Biology

|November 10, 2021

Summary

Mutations in the MPL gene activate the thrombopoietin receptor (TPOR), driving myeloproliferative neoplasms (MPN). Understanding these MPL mutations is key to developing new therapies for MPN and familial thrombocytosis.

Keywords:

Hereditary thrombocytosis MPL Mutations Myeloproliferative Neoplasms Thrombocytosis Thrombopoietin receptor

More Related Videos

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Identifying Mutations by High Resolution Melting in a TILLING Population of Rice

Identifying Mutations by High Resolution Melting in a TILLING Population of Rice

Published on: September 2, 2019

Related Experiment Videos

Last Updated: Oct 13, 2025

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Identifying Mutations by High Resolution Melting in a TILLING Population of Rice

Identifying Mutations by High Resolution Melting in a TILLING Population of Rice

Published on: September 2, 2019

Area of Science:

Hematology
Molecular Biology
Genetics

Background:

Myeloproliferative neoplasms (MPN) are driven by mutations in JAK2, MPL, or CALR genes.
These mutations lead to the activation of the thrombopoietin receptor (TPOR) and associated signaling pathways.
JAK2 mutations are implicated in Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis via TPOR, EPOR, and CSF3R signaling.

Purpose of the Study:

To elucidate the role of MPL mutations in the pathogenesis of MPN.
To review somatic and germline genetic variants of MPL and their impact on clinical phenotypes.
To explore novel therapeutic strategies targeting MPL-driven signaling in MPN.

Main Methods:

Review of existing literature on MPL mutations in MPN.
Analysis of molecular mechanisms underlying TPOR activation by MPL mutants.
Correlation of genetic variants with clinical manifestations in MPN and familial thrombocytosis.

Main Results:

MPL mutations cause stable dimerization of TPOR, activating JAK2 and the thrombopoietin pathway.
MPL mutations are linked to thrombocytosis, abnormal MPL trafficking, and receptor activation.
Rare germline MPL variants can lead to hereditary MPN-like diseases.

Conclusions:

TPOR is central to MPN development, and MPL mutations are crucial for understanding MPN pathogenesis.
MPL mutations offer targets for novel therapeutic strategies to disrupt dysregulated signaling.
Understanding MPL's role is vital for diagnosing and treating MPN and familial thrombocytosis.